Group 1: BioCryst Pharmaceuticals, Inc. (BCRX) - BioCryst has a Zacks Rank 1 and the Zacks Consensus Estimate for its current year earnings increased by 285.7% over the last 60 days [1] - The company's shares gained 15% over the last three months, while the S&P 500 declined by 7.2% [1] - BioCryst possesses a Momentum Score of A [1] Group 2: WidePoint Corporation (WYY) - WidePoint has a Zacks Rank 1 and the Zacks Consensus Estimate for its current year earnings increased by 108.3% over the last 60 days [2] - The company's shares gained 35.7% over the last three months, compared to the S&P 500's decline of 7.2% [2] - WidePoint possesses a Momentum Score of B [2] Group 3: Rambus Inc. (RMBS) - Rambus has a Zacks Rank 1 and the Zacks Consensus Estimate for its current year earnings increased by 3.9% over the last 60 days [3] - The company's shares gained 11.6% over the past month, while the S&P 500 advanced by 6.9% [3] - Rambus possesses a Momentum Score of B [3]

Group 1 - Chain Bridge Bancorp, Inc. (CBNA) has seen a 9.5% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Fresenius Medical Care AG (FMS) has experienced a 4.5% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Brenntag SE (BNTGY) has seen a 14.1% increase in the Zacks Consensus Estimate for its next year earnings over the last 60 days [2] - WidePoint Corporation (WYY) has experienced a significant 108.3% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - BioCryst Pharmaceuticals, Inc. (BCRX) has seen an impressive 285.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [3]